Veracyte

Veracyte Q1 Revenues Jump 85 Percent

Veracyte Revenues Almost Double in Q4

In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More

Veracyte Q3 Revenues Nearly Double

360Dx Index Continues Growth in July, Increasing 5 Percent

Veracyte Q2 Revenues More Than Double on Test Volume Spike

Veracyte Bladder Cancer Test Receives Medicare Coverage

Veracyte to Acquire HalioDx for €260M

May Lag for Many Dx Firms' Stock Prices as 360Dx Index Drops 4 Percent

Veracyte Q1 Revenues Up 18 Percent; CEO Transition Underway

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

In Brief This Week: Grail, Illumina, Veracyte, Aspira Women's Health, and More

Veracyte Q4 2020 Revenues Rise 16 Percent

In Brief This Week: Roche, Quanterix, Ortho Clinical Diagnostics, Veracyte, and More

Veracyte Prices $550M Public Offering of Common Stock